Analysed AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) News Sources
Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
14-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading
14-05-2026
yahoo.com
Autolus Therapeutics PLC (AUTL) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
14-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
18-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
19-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
21-05-2026
yahoo.com
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
21-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
22-05-2026
yahoo.com
What is the current price of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The current price of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is $1.68.
AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) since the previous trading day is $0.
AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The most recent average sentiment score for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)?
The most recent sentiment for AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ) is .
SEC-8K** Filing Available For AUTOLUS THERAPEUTICS PLC (AUTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.